Abstract

Introduction: Despite the rapid growth of aortic valve replacement (AVR) for aortic stenosis (AS), studies have suggested that symptomatic severe AS remains undertreated. Hypothesis: The growth in patients with an indication for AVR has outpaced the number of AVRs performed. Methods: We identified patients with severe AS (aortic valve area <1cm 2 ) on transthoracic echocardiograms from 2000-2017 at two large academic medical centers. Natural language processing (NLP) models were developed and validated to identify symptoms consistent with severe AS, and patients were classified based on ACC/AHA clinical guideline indications for AVR. Patients were divided into groups based on mean aortic valve gradient (mAVG≥ 40 or <40mmHg) and left ventricular ejection fraction (LVEF≥50% or <50%). Utilization of AVR (transcatheter aortic valve implantation [TAVI] or surgical aortic valve replacement [SAVR]) in patients with a clinical indication was examined over time, and clinical predictors of AVR were identified via multivariate logistic regression. Results: A total of 10,795 AS patients were included in this analysis, of whom 6,150 (57%) had an indication or potential indication for AVR and 2,976 (48%) received AVR. The frequency of AVR varied by AS subtype (HG-NEF: 69%, HG-LEF: 53%, LG-NEF: 32%, LG-LEF: 38%, p<0.001). The adoption of TAVI contributed to the growth in AVR volume over time, however there has been a parallel rise in the number of patients with an indication for AVR (Figure). In patients with a class I indication for AVR, younger age, coronary artery disease, smoking history, higher hematocrit, outpatient index TTE, and LVEF≥0.5 were independently associated with an increased likelihood of receiving an AVR. Conclusions: Over an 18-year study period, the proportion of patients with an indication for AVR who do not receive AVR has remained significant despite the rapid growth of AVR volumes.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call